Association ofMUC16Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors-Reference-Cited by-同舟云学术

Association ofMUC16Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors

Published:2020-08-26 Issue:8 Volume:3 Page:e2013201
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Zhang Lei¹,Han Xiaohong¹²,Shi Yuankai¹

Affiliation:

1. Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

2. Clinical Pharmacology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2769828/zhang_2020_oi_200498_1602696288.25976.pdf

Reference38 articles.

1. The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy.;Havel;Nat Rev Cancer,2019

2. Genomic correlates of response to immune checkpoint blockade.;Keenan;Nat Med,2019

3. MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress.;Felder;Mol Cancer,2014

4. MUC16 as a novel target for cancer therapy.;Aithal;Expert Opin Ther Targets,2018

5. Association of MUC16 mutation with tumor mutation load and outcomes in patients with gastric cancer.;Li;JAMA Oncol,2018

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant gemcitabine–cisplatin plus tislelizumab in persons with resectable muscle-invasive bladder cancer: a multicenter, single-arm, phase 2 trial;Nature Cancer;2024-09-10

2. The combination of exon sequencing and metabolomics to establish a molecular typing system for gastric cancer;Heliyon;2024-08

3. MUC16: clinical targets with great potential;Clinical and Experimental Medicine;2024-05-17

4. Identification of collagen subtypes of gastric cancer for distinguishing patient prognosis and therapeutic response;Cancer Innovation;2024-05-16

5. Construction and analysis of a reliable five-gene prognostic signature for colon adenocarcinoma associated with the wild-type allelic state of the COL6A6 gene;Translational Cancer Research;2024-05